RESUMEN
Streptomycin, an antimicrobial with limited availability, is the treatment of choice for plague, a fulminating and potentially epidemic disease that poses a bioterrorism concern. We evaluated the efficacy of gentamicin and tetracyclines for treating human plague. A medical record review was conducted on all 75 patients with plague who were reported in New Mexico during 1985-1999. Fifty patients were included in an analysis that compared streptomycin-treated patients (n=14) with those treated with gentamicin and/or a tetracycline (n=36). The mean numbers of fever days, hospital days, and complications and the number of deaths did not differ between patients treated with streptomycin and those treated with gentamicin. One patient who received tetracycline alone experienced a serious complication. Gentamicin alone or in combination with a tetracycline was as efficacious as streptomycin for treating human plague. The efficacy of a tetracycline alone could not be determined from the study.
Asunto(s)
Quimioterapia Combinada/uso terapéutico , Gentamicinas/uso terapéutico , Peste/tratamiento farmacológico , Tetraciclinas/uso terapéutico , Adulto , Femenino , Humanos , Tiempo de Internación , Masculino , Peste/complicaciones , Peste/mortalidad , Estudios Retrospectivos , Estreptomicina/uso terapéutico , Yersinia pestis/efectos de los fármacosRESUMEN
OBJECTIVES: To describe demographic characteristics, patterns of use, and symptoms associated with mercury poisoning among persons who used a Mexican beauty cream containing mercurous chloride and to estimate the prevalence of cream use in Texas near the Mexico border. DESIGN: Case series and cross-sectional survey. SETTING: Border communities of Arizona, California, New Mexico, and Texas. PARTICIPANTS: Persons who used the cream and contacted a health department in response to announcements about the cream and households that participated in the Survey of Health and Environmental Conditions in Texas Border Counties and Colonias, 1997. MAIN OUTCOME MEASURES: Urine mercury concentrations, self-reported symptoms, and prevalence of cream use among households. RESULTS: Of 330 cream users who contacted their health department, 96% were women, and 95% were Hispanic. The mean urine mercury concentration was 146.7 microg/L (reference range : 0-20 microg/L). In 5% of 2,194 randomly selected Texas households near the Mexico border, at least 1 person had used "Crema de Belleza-Manning" (Laboratorios Vida Natural, S.A., Tampico, Tamaulipas, Mexico) in the previous year. CONCLUSIONS: Most cream users had increased urine mercury concentrations. Cream use was common in Texas near the Mexico border. Physicians should consider toxicity in patients with neurologic symptoms of unclear cause and use public health departments when investigating unusual illnesses.